Another indication

FRIDAY, Feb. 29 (HealthDay News) — The U.S. Food and Drug Administration has approved Abilify (aripiprazole) to treat manic and mixed episodes in children aged 10 to 17 with bipolar 1 disorder, makers Otsuka Pharmaceutical Co. and Bristol-Myers Squibb Inc. said Friday.The drug has been approved for this and other uses in adults for several [...]